Drugs A-Z Is my price fair? Price changes Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IIITerminatedD-0650-2016

Drug recall · February 10, 2016

Clonazepam Tablets recall

Why: Failed Impurities/Degradation Specifications: out of specification result for known impurity at 6 month timepoint.

Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).

The recall

Product

Clonazepam Tablets, USP, 0.5 mg, 100-count carton, Rx only, Manufactured by Mylan Pharmaceuticals Inc., Morgantown, WV, 26505, NDC:51079-881-21

Lots / codes

Lot # 3063759, Exp.07/16

Quantity
868 unit cartons (86,800 tablets)
Company
Mylan Institutional, Inc. (d.b.a. UDL Laboratories), Rockford, IL
Distribution
Nationwide
Initiated
January 28, 2016 · Voluntary: Firm initiated
Classified
February 2, 2016
Reported
February 10, 2016
Ended
December 21, 2016
How notified
Letter

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Clonazepam

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.